All In Biotech

Free tool

FAERS Monitor: Evdi

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 220837 or its brand name (Evdi, Trabectedin). Reports on generic versions are filed under their own applications.

Reports

1,205

Serious

1,178

98% of reports

Hospitalization

547

Death reported

261

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • neutropenia159
  • anaemia133
  • thrombocytopenia132
  • disease progression118
  • nausea109
  • febrile neutropenia107
  • drug ineffective93
  • vomiting92
  • off label use86
  • asthenia72
  • fatigue66
  • pancytopenia64
  • pyrexia60
  • leukopenia56
  • rhabdomyolysis54

Reports by year received

View as table
YearReports
20061
20073
20083
20092
201011
201132
201219
201312
201414
201548
2016101
201791
2018121
2019127
202094
202171
202288
2023100
2024107
202577
202683

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,954 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
febrile neutropeniaSignal10728.223.52,784
rhabdomyolysisSignal5422.617.41,096
thrombocytopeniaSignal13220.617.62,456
neutropeniaSignal15920.417.72,935
pancytopeniaSignal6420.015.81,139
leukopeniaSignal5619.615.1969
disease progressionSignal11817.414.71,819
anaemiaSignal13312.210.41,365
vomitingSignal923.42.8158
astheniaSignal723.32.7118
pyrexiaSignal603.02.481
nauseaSignal1092.42.091
off label use861.71.426
fatigue661.51.210
drug ineffective931.21.04

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.